ATE476185T1 - Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen - Google Patents
Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungenInfo
- Publication number
- ATE476185T1 ATE476185T1 AT04766789T AT04766789T ATE476185T1 AT E476185 T1 ATE476185 T1 AT E476185T1 AT 04766789 T AT04766789 T AT 04766789T AT 04766789 T AT04766789 T AT 04766789T AT E476185 T1 ATE476185 T1 AT E476185T1
- Authority
- AT
- Austria
- Prior art keywords
- ciclesonide
- inflammatory bowel
- bowel disease
- treat inflammatory
- treat
- Prior art date
Links
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 title abstract 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 title abstract 2
- 229960003728 ciclesonide Drugs 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03020871 | 2003-09-15 | ||
| PCT/EP2004/052170 WO2005025577A1 (en) | 2003-09-15 | 2004-09-15 | Use of ciclesonide for the treatment of inflammatory bowel diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE476185T1 true ATE476185T1 (de) | 2010-08-15 |
Family
ID=34306766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04766789T ATE476185T1 (de) | 2003-09-15 | 2004-09-15 | Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060211668A1 (de) |
| EP (1) | EP1670481B1 (de) |
| JP (1) | JP5371189B2 (de) |
| AT (1) | ATE476185T1 (de) |
| AU (1) | AU2004271743B2 (de) |
| CA (1) | CA2538202C (de) |
| DE (1) | DE602004028497D1 (de) |
| ES (1) | ES2350396T3 (de) |
| WO (1) | WO2005025577A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2407476B1 (de) * | 2009-03-09 | 2014-05-07 | Mikasa Seiyaku Co,. Ltd. | Steroidverbindung |
| GB201202433D0 (en) | 2012-02-13 | 2012-03-28 | Diurnal Ltd | Controlled drug release |
| EP3613414A1 (de) * | 2018-08-24 | 2020-02-26 | Dr. Falk Pharma Gmbh | Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643602A (en) * | 1989-11-22 | 1997-07-01 | Astra Aktiebolag | Oral composition for the treatment of inflammatory bowel disease |
| SE8903914D0 (sv) * | 1989-11-22 | 1989-11-22 | Draco Ab | Oral composition for the treatment of inflammatory bowel diseases |
| US5178866A (en) * | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| CN1062869C (zh) * | 1993-04-02 | 2001-03-07 | 比克·古尔顿·劳姆贝尔格化学公司 | 新型脱氢皮质醇衍生物 |
| DE4332394A1 (de) * | 1993-09-23 | 1995-03-30 | Falk Pharma Gmbh | Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung |
| US5811388A (en) * | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
| SE514128C2 (sv) * | 1998-03-17 | 2001-01-08 | Pharmalink Ab | Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit |
| US6096731A (en) * | 1998-06-24 | 2000-08-01 | Institute For Drug Research, Inc. | Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation |
| DE10214002A1 (de) * | 2002-03-27 | 2003-10-09 | Roehm Gmbh | Pharmazeutische Formulierung für den Wirkstoff Budesonid |
-
2004
- 2004-09-15 EP EP04766789A patent/EP1670481B1/de not_active Expired - Lifetime
- 2004-09-15 WO PCT/EP2004/052170 patent/WO2005025577A1/en not_active Ceased
- 2004-09-15 AT AT04766789T patent/ATE476185T1/de active
- 2004-09-15 DE DE602004028497T patent/DE602004028497D1/de not_active Expired - Lifetime
- 2004-09-15 JP JP2006525841A patent/JP5371189B2/ja not_active Expired - Lifetime
- 2004-09-15 US US10/570,986 patent/US20060211668A1/en not_active Abandoned
- 2004-09-15 AU AU2004271743A patent/AU2004271743B2/en not_active Expired
- 2004-09-15 ES ES04766789T patent/ES2350396T3/es not_active Expired - Lifetime
- 2004-09-15 CA CA2538202A patent/CA2538202C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004028497D1 (de) | 2010-09-16 |
| AU2004271743A1 (en) | 2005-03-24 |
| JP2007505828A (ja) | 2007-03-15 |
| CA2538202A1 (en) | 2005-03-24 |
| JP5371189B2 (ja) | 2013-12-18 |
| EP1670481B1 (de) | 2010-08-04 |
| EP1670481A1 (de) | 2006-06-21 |
| WO2005025577A1 (en) | 2005-03-24 |
| US20060211668A1 (en) | 2006-09-21 |
| ES2350396T3 (es) | 2011-01-21 |
| AU2004271743B2 (en) | 2010-06-10 |
| CA2538202C (en) | 2013-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| ATE512663T1 (de) | Kombination zur behandlung von erkrankungen mit zellproliferation | |
| ATE544748T1 (de) | Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen | |
| DE60303238D1 (de) | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten | |
| EP1742675A4 (de) | Behandlung von biomedizinischem abfall | |
| DE602004028763D1 (de) | Te zur behandlung von virenerkrankungen | |
| ATE453653T1 (de) | Platinkomplexe zur behandlung von tumoren | |
| ATE526991T1 (de) | Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| ATE443704T1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| EP1965827A4 (de) | Behandlung von entmyelinisierenden erkrankungen | |
| SE0302304D0 (sv) | Novel compounds | |
| DE602004022035D1 (de) | Verwendung von pthalide derivativen zur behandlung | |
| NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
| DE602004026597D1 (de) | Behandlung von alzheimer-krankheit und verwandten zuständen | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| DE602004009414D1 (de) | BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN MIT N-2,3,3-TETRAMETHYLBICYCLOi2.2.1öHEPTAN-2-AMINE | |
| ATE476185T1 (de) | Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen | |
| DE602004024871D1 (de) | Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten | |
| ATE392212T1 (de) | Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen | |
| ATE347883T1 (de) | Verwendung von n-(2-aryl-propionyl)-sulfonamiden zur behandlung von rückenmarkverletzungen | |
| DE602005015434D1 (de) | Mittel zur behandlung von psychoneurotischen krankheiten | |
| EA200600314A1 (ru) | Использование растворимого cd164 при воспалительных и/или аутоимунных нарушениях | |
| ATE482707T1 (de) | 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1670481 Country of ref document: EP |